Freeman Chris

SEC Form 4 insider
Chief Commercial Officer · Guardant Health, Inc. ($GH)
1 thesis · first seen Aug 11, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d000———
3d111100%-4.8%-4.8%
1w111100%-3.0%-3.0%
1m111100%-3.7%-3.7%
3m111100%-3.8%-3.8%
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$GHSEC Form 4bearish
Sold 63,605 @ $169.58 avg · $10,786,111 · 2026-08-10

Form 4: Freeman Chris sold GH

Freeman Chris (Chief Commercial Officer at Guardant Health, Inc.) reported an open-market sale of 63,605 shares of GH at an average $169.58, roughly $10,786,111, in a Form 4 filed 2026-08-11.

At post $165.11Now $151.70-8.1% since postedas of Nov 13, 4:45 PM ET
1d—
3d-4.8%
1w-3.0%
1m-3.7%
3m-3.8%
6m—
1y—
View filing on SEC.gov →

End of results.